NM
Naga Malleswari Janga
About Naga Malleswari Janga
Data last updated:
Naga Malleswari Janga is a Designated Partner at Starion Life Sciences Llp (since 2026). The companies operate in Chemicals. Earlier, Naga Malleswari Janga was a Director at Sandiego Pharmaceuticals India Private Limited (2024–2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Starion Life Sciences Llp ACV-4303 | Designated Partner | 16 Feb 2026 | 2026 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Sandiego Pharmaceuticals India Private Limited U24299KA2021PTC147836 | Director | 30 Aug 2024 | 2021 | ₹98.7 Lakh (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Naga Malleswari Janga
| Name | DIN | Company | Designation |
|---|---|---|---|
| Niranjan Reddy Reddeppagari | 11548856 | Starion Life Sciences Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Naga Malleswari Janga
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Naga Malleswari Janga
Naga Malleswari Janga currently holds 1 directorship: Starion Life Sciences Llp (Designated Partner, since 16 Feb 2026).
Naga Malleswari Janga was first appointed on 30 Aug 2024 as Director at Sandiego Pharmaceuticals India Private Limited. The most recent appointment on record is 16 Feb 2026 at Starion Life Sciences Llp.
Naga Malleswari Janga held 1 earlier board appointment: Sandiego Pharmaceuticals India Private Limited (Director, 30 Aug 2024 to 14 Feb 2026).
The current boards of Naga Malleswari Janga's companies include Niranjan Reddy Reddeppagari (Starion Life Sciences Llp).